New & Improved!

Submit a New & Noteworthy
November 2018
CSTD Conforms to NIOSH Protocol
By: Equashield LLC

CSTD Conforms to NIOSH Protocol

A recent study conducted by the University of North Carolina evaluated six CSTD systems on the market, using isopropyl alcohol as a surrogate for chemotherapy medication, per NIOSH’s 2015 proposed testing protocol. Equashield was found to adequately contain hazardous drug vapors and aerosols throughout the compounding and administration process. Containment of hazardous vapors is one of several factors used to assess the effectiveness of CSTDs, and use of isopropyl alcohol serves as a realistic worst case surrogate for such assessment.

Equashield LLC

Click here to view product detail on Findit.

Current Issue

Enter our Sweepstakes now for your chance to win the following prizes:

    Just answer the following quick question for your chance to win:

    To continue, you must either login or register:

    As of May 24, 2018,'s Terms of Use and Privacy Policy have been updated.
    You can review the Terms of Use HERE and the Privacy Policy HERE.
    By continuing to use, you are agreeing to these changes.